The dual GLP-1/GIP mechanism creates potent metabolic effects at lower doses than single-target agonists
Experts recommend recovering by drinking plenty of fluids, avoiding solid foods, and resting if you are experiencing norovirus symptoms
expounded on the obesity paradox, suggesting increased BMD is offset by poor bone quality due to advanced glycation end-products (AGEs) accumulation, impaired osteoblast function, and uncoupled bone turnover favoring resorption
It is important to remember that efficacy varies from person to person: the tolerated dose, adherence to treatment, lifestyle and the quality of follow-up all play a part
Since it might be argued that Ca 2+ stores were simply depleted under conditions in which the SES contained 100 nM Ca 2+ , we compared the Ca 2+ mobilizing properties of a purinergic receptor agonist (ATP) under conditions in which the SES contained 2.6 mM Ca 2+ or 100 nM Ca 2+
While GLP-1s offer a promising solution for weight loss, they come at a staggering cost